Xr Securities LLC Gilead Sciences, Inc. Transaction History

Xr Securities LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$63.47 - $69.35 $345,974 - $378,026	-5,451 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$60.0 - $68.46 $327,060 - $373,175	5,451 New	5,451 $352,000
Q1 2020 Apr 09, 2020	SELL	$62.63 - $80.22 $848,323 - $1.09 Million	-13,545 Closed	0 $0
Q4 2019 Jan 06, 2020	BUY	$61.62 - $67.78 $254,798 - $280,270	4,135 Added 43.94%	13,545 $880,000
Q3 2019 Oct 03, 2019	BUY	$62.51 - $69.0 $195,281 - $215,556	3,124 Added 49.7%	9,410 $596,000
Q2 2019 Jul 10, 2019	BUY	$61.87 - $69.38 $69,665 - $78,121	1,126 Added 21.82%	6,286 $425,000
Q1 2019 Apr 08, 2019	SELL	$62.53 - $70.05 $2.09 Million - $2.34 Million	-33,467 Reduced 86.64%	5,160 $335,000
Q4 2018 Jan 03, 2019	BUY	$60.54 - $79.0 $1.69 Million - $2.2 Million	27,843 Added 258.19%	38,627 $2.42 Million
Q3 2018 Oct 04, 2018	BUY	$71.28 - $78.92 $329,527 - $364,847	4,623 Added 75.04%	10,784 $833,000
Q2 2018 Jul 06, 2018	BUY	$64.88 - $75.68 $399,725 - $466,264	6,161 New	6,161 $436,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Xr Securities LLC with notifications on news.